Pharmaceuticals Company Reports Market Research Reports & Industry Analysis

Research your competitors and discover new corporate prospects in the pharmaceutical industry with company reports and profiles.
...Show More ...Show Less


Pharmaceuticals Company Reports Industry Research & Market Reports

  • Blood Disease Drugs Companies in China

    ... dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies ... Read More

  • Generic Drugs Companies in China

    ... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ... Read More

  • Depression Treatment Drugs Companies in China

    ... dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies ... Read More

  • Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2016-2022

    ... to the collaborative R&D deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest collaborative R&D deals announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully ... Read More

  • Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2016-2022

    ... to the licensing deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest licensing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully up to ... Read More

  • Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2015-2022

    ... unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies. This report provides details of the latest co-promotion and co-marketing agreements announced in the pharmaceutical, biotechnology and diagnostic ... Read More

  • Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 to 2022

    ... to the co-development deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest Co-development agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and ... Read More

  • Global Cardiovascular Partnering 2015-2022: Deal trends, players and financials

    ... in Cardiovascular partnering deals Financial deal terms for headline, upfront and royalty by stage of development Cardiovascular partnering agreement structure Cardiovascular partnering contract documents Top Cardiovascular deals by value Most active Cardiovascular dealmakers Most of ... Read More

  • Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 to 2022

    ... agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of distribution agreements from 2015 to 2022. The report provides a detailed understanding and analysis of how and ... Read More

  • Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022

    ... of the latest option and evaluation agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of option and evaluation agreements from 2015 to 2022. There are two ... Read More

  • Global Gastrointestinal Partnering 2015-2022: Deal trends, players and financials

    ... in Gastrointestinal partnering deals Financial deal terms for headline, upfront and royalty by stage of development Gastrointestinal partnering agreement structure Gastrointestinal partnering contract documents Top Gastrointestinal deals by value Most active Gastrointestinal dealmakers Most of ... Read More

  • Global Dermatology Partnering 2015-2022: Deal trends, players and financials

    ... by the worlds leading healthcare companies. Trends in Dermatology partnering deals Financial deal terms for headline, upfront and royalty by stage of development Dermatology partnering agreement structure Dermatology partnering contract documents Top Dermatology deals by ... Read More

  • Global Central Nervous System Partnering 2015-2022: Deal trends, players and financials

    ... and biotechnology companies since 2015. Trends in Central Nervous System partnering deals Financial deal terms for headline, upfront and royalty by stage of development Central Nervous System partnering agreement structure Central Nervous System partnering contract ... Read More

  • Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022

    ... to the joint venture deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest joint venture agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully ... Read More

  • Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2022

    ... of transactions, including the technology licensed, royalty rates, license fees, upfront and milestone payments. This report provides details of the latest partnering deals which disclose a royalty rate, announced in the pharmaceutical, biotechnology and diagnostic ... Read More

  • Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015 to 2022

    ... how and why companies enter business, product, technology and royalty assets. The report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets. The focus of the ... Read More

  • Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022

    ... of the latest manufacturing and supply agreements announced in the pharmaceutical, biotechnology, device and diagnostic sectors. Fully revised and updated, the report provides details of manufacturing and supply agreements from 2015 to 2022. The report ... Read More

  • Global Genetic Disorders Partnering 2015-2022: Deal trends, players and financials

    ... since 2015. Trends in Genetic Disorders partnering deals Financial deal terms for headline, upfront and royalty by stage of development Genetic Disorders partnering agreement structure Genetic Disorders partnering contract documents Top Genetic Disorders deals by ... Read More

  • Cancer Therapies

    ... projected to reach a revised size of US$254.4 Billion by 2027, growing at a CAGR of 8.9% over the analysis period 2020-2027. Chemotherapy, one of the segments analyzed in the report, is projected to record ... Read More

  • Consumer Health in the Czech Republic

    ... and oil. This will have an overall negative effect on the growth of the Czech economy. Before Russia's invasion, the Czech economy was seeing growth of between 3-4%. For the rest of the year, inflation ... Read More

  • Consumer Health in Singapore

    ... symptoms of COVID-19 evolved to resemble those of the common cold, prompting consumers to purchase over-the-counter remedies for preventive health and self-medication purposes in Q1 2022. Despite further variants emerging in 2022, Singaporeans are increasingly ... Read More

  • Consumer Health in Spain

    ... of COVID-19: The bulk of the local population was fully vaccinated by the end of 2021, with many receiving additional booster shots in 2022. Meanwhile, the ending of compulsory mask wearing in most public spaces ... Read More

  • Consumer Health in Chile

    ... largely depended on demand for categories such as analgesics, sleep aids, vitamins and dietary supplements, weight management and wellbeing and dermatologicals. This was closely linked to two factors: some categories, such as multivitamins, benefited from ... Read More

  • Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028, NAIC 325400

    ... save countless hours of research. Key Findings: Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.) to reach $318,715,446,873 million by 2029. Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry, including Average EBITDA, Operating Ratios and Sales ... Read More

  • SPI Pharma Inc - Strategic SWOT Analysis Review

    ... key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope ... Read More

< prev 1 2 3 4 5 6 7 8 9 10

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings